Affinivax
Affinivax
Next generation vaccine technology platform
Human health & social work | United States of America | Capacity Building |
Overview
Affinivax is developing novel vaccines based on its proprietary technology platform the Multiple Antigen Presenting System (MAPS). Working with world experts in vaccine discovery and development Affinivax is building a pipeline of innovative vaccines to achieve broader protection against a wide range of diseases including those for which there are no effective vaccines available today.
Industry |
Legal Structure |
Operating Status |
Employees |
Human health & social work | Operating | 2 - 10 employees |
Funding and Financing Rounds
Jun, 2014 / PRI / Cash & Convertible Note
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters
Cambridge, Massachusetts United States of America